These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15806426)

  • 21. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.
    Kharasch ED; Hoffer C; Walker A; Sheffels P
    Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single plasma sampling to predict oral clearance of CYP3A probe midazolam.
    Zhu B; Ou-Yang DS; Cheng ZN; Huang SL; Zhou HH
    Acta Pharmacol Sin; 2001 Jul; 22(7):634-8. PubMed ID: 11749829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
    Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-point plasma or urine dextromethorphan method for determining CYP3A activity.
    Kuo BP; Hu OY; Hsiong CH; Pao LH; Chen TS; Hung CF
    Biopharm Drug Dispos; 2003 Dec; 24(9):367-73. PubMed ID: 14689465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of the newer benzodiazepines.
    Garzone PD; Kroboth PD
    Clin Pharmacokinet; 1989 Jun; 16(6):337-64. PubMed ID: 2567646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam.
    Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Hayashi K; Chiba K; Ishizaki T
    Neuropsychopharmacology; 1997 Jan; 16(1):8-14. PubMed ID: 8981384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite.
    Agarwal V; Kommaddi RP; Valli K; Ryder D; Hyde TM; Kleinman JE; Strobel HW; Ravindranath V
    PLoS One; 2008 Jun; 3(6):e2337. PubMed ID: 18545703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
    Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF
    Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite.
    Pai HV; Upadhya SC; Chinta SJ; Hegde SN; Ravindranath V
    Pharmacogenomics J; 2002; 2(4):243-58. PubMed ID: 12196913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fatality due to alprazolam intoxication.
    Jenkins AJ; Levine B; Locke JL; Smialek JE
    J Anal Toxicol; 1997; 21(3):218-20. PubMed ID: 9171206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of CYP3A inhibition on the metabolism of cilostazol.
    Suri A; Forbes WP; Bramer SL
    Clin Pharmacokinet; 1999; 37 Suppl 2():61-8. PubMed ID: 10702888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
    Greene DS; Salazar DE; Dockens RC; Kroboth P; Barbhaiya RH
    J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alprazolam in end-stage renal disease: I. Pharmacokinetics.
    Schmith VD; Piraino B; Smith RB; Kroboth PD
    J Clin Pharmacol; 1991 Jun; 31(6):571-9. PubMed ID: 1880224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers.
    Wong SL; Locke C; Staser J; Granneman GR
    Psychopharmacology (Berl); 1998 Feb; 135(3):236-41. PubMed ID: 9498726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
    Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes.
    Warrington JS; Poku JW; von Moltke LL; Shader RI; Harmatz JS; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1024-31. PubMed ID: 10688619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alprazolam, alpha-hydroxy- and 4-hydroxyalprazolam analysis in plasma by high-performance liquid chromatography.
    Miller RL; DeVane CL
    J Chromatogr; 1988 Aug; 430(1):180-6. PubMed ID: 3215955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.